EMA Expert Advice Pilot Could Be ‘Vital Source Of Guidance’ For SMEs
Executive Summary
Ten medical device manufacturers will receive scientific advice from expert panels on their product clinical development strategies under a new European Medicines Agency pilot scheme. But who will it ultimately benefit and what does the scheme entail?
You may also be interested in...
Manufacturers Can Now Apply For Clinical Advice Under EU Expert Panel Pilot
Manufacturers of high-risk medical devices who would benefit from advice on their intended clinical development strategies for innovative products are being invited to submit a letter of interest to the European Medicines Agency under a pilot scheme.
Expert Panels To Offer Some Device Manufacturers Scientific Advice Under EU Pilot
Manufacturers of high-risk class III medical devices and class IIb active medical devices that administer or remove medicinal products from the human body will be able to access expert panel advice prior to applying for CE-marking under a newly-announced European Medicines Agency pilot scheme.
Huma Secures EU MDR Approval For Medtech Software That Can Be Used In Any Disease
Huma Therapeutics has secured the first ever EU regulatory approval for a “disease agnostic” class IIb medtech software platform. CEO Dan Vahdat tells Medtech Insight how the product can be configured to monitor patients with any condition.